PHOENIX, April 29, 2016 /PRNewswire/ -- Americans consume an average of 22 to 30 teaspoons of sugar a day1 and many are struggling with the metabolic consequences of excess — 69% are overweight or obese.2 Mineral Biosciences® GlyDe® D undercuts the sugar metabolism problem by defending against glycation.
Eating too much sugar and starch raises blood sugar and if levels become chronically high, risk increases for many diseases and disorders. Excess sugar combines with proteins and forms harmful rogue molecules called advanced glycation end products, or AGEs.3 AGEs make a human body age faster, by damaging every type of cell, in nerves, organs, arteries, and the skin.
GlyDe® D contains a one-of-a-kind ingredient, Totála® Ionic Mineral Complex, which is patented for treating or preventing glycation — a process formally known as anti-glycation. It defends against rogue AGEs. The ingredient is a proprietary composition of at least 68 major, minor, and trace minerals used by the human body for optimum function, including selenium, zinc, magnesium, calcium, iron, sodium, potassium, phosphorus, copper, silicon, boron, manganese, iodine, molybdenum, chromium, sulfur, strontium, and vanadium.
Glycation can be detected with the same tests that measure chronic levels of blood sugar, and these have been used in studies of the patented mineral complex. When glycation decreases, so do levels of blood sugar, indicating healthier sugar metabolism.
A study published in the International Journal for Vitamin and Nutrition Research4 tested the proprietary mineral complex in GlyDe D on human cells and in diabetic mice. Researchers concluded: "To our best knowledge, this is the first description ever of a fossil material having anti-diabetic activity in pre-clinical models." While GlyDe® D is not a treatment for diabetes, the research demonstrates that this patented extract has a beneficial effect on the metabolism of sugar.
1 By Any Other Name It's Still Sweetener. American Heart Association.
2 Obesity and Overweight. National Center for Health Statistics, Centers for Disease Control and Prevention.
3 Advanced glycation end products (AGEs) and their receptors (RAGEs) in diabetic vascular disease. Medicographia.
4 Anti-diabetic activity of a mineraloid isolate, in vitro and in genetically diabetic mice. Deneau J, Ahmed T, Blotsky R, Bojanowski K. International Journal for Vitamin and Nutrition Research. 2011 Jan;81(1):34-42. (Full study available on request.)
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mineral-biosciences-glyde-d-undercuts-todays-sugar-metabolism-problem-300259907.html
SOURCE Mineral Biosciences